Liver Fat and Insulin Resistance Are Independently Associated with the −514C>T Polymorphism of the Hepatic Lipase Gene

Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. Objective: First, our object was to investigate whether the functional −514C>T polymorph...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 90; no. 7; pp. 4238 - 4243
Main Authors Stefan, Norbert, Schäfer, Silke, Machicao, Fausto, Machann, Jürgen, Schick, Fritz, Claussen, Claus D, Stumvoll, Michael, Häring, Hans-Ulrich, Fritsche, Andreas
Format Journal Article
LanguageEnglish
Published Bethesda, MD Endocrine Society 01.07.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. Objective: First, our object was to investigate whether the functional −514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 on liver fat content and insulin sensitivity. Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat. Results: The −514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the −514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the −514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism. Conclusions: The −514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2. These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance.
AbstractList Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. Objective: First, our object was to investigate whether the functional −514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 on liver fat content and insulin sensitivity. Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat. Results: The −514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the −514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the −514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism. Conclusions: The −514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2. These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance.
Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. First, our object was to investigate whether the functional -514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma(2) on liver fat content and insulin sensitivity. Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat. The -514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the -514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the -514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism. The -514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(2). These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance.
CONTEXTLiver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism.OBJECTIVEFirst, our object was to investigate whether the functional -514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma(2) on liver fat content and insulin sensitivity.DESIGN AND METHODSCross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat.RESULTSThe -514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the -514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the -514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism.CONCLUSIONSThe -514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(2). These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance.
CONTEXT: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism. OBJECTIVE: First, our object was to investigate whether the functional -514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor- gamma sub(2) on liver fat content and insulin sensitivity. Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat. RESULTS: The -514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the -514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the -514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism. CONCLUSIONS: The -514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor- gamma sub(2). These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance.
Author Machann, Jürgen
Häring, Hans-Ulrich
Schäfer, Silke
Schick, Fritz
Claussen, Claus D
Machicao, Fausto
Fritsche, Andreas
Stefan, Norbert
Stumvoll, Michael
Author_xml – sequence: 1
  givenname: Norbert
  surname: Stefan
  fullname: Stefan, Norbert
– sequence: 2
  givenname: Silke
  surname: Schäfer
  fullname: Schäfer, Silke
– sequence: 3
  givenname: Fausto
  surname: Machicao
  fullname: Machicao, Fausto
– sequence: 4
  givenname: Jürgen
  surname: Machann
  fullname: Machann, Jürgen
– sequence: 5
  givenname: Fritz
  surname: Schick
  fullname: Schick, Fritz
– sequence: 6
  givenname: Claus D
  surname: Claussen
  fullname: Claussen, Claus D
– sequence: 7
  givenname: Michael
  surname: Stumvoll
  fullname: Stumvoll, Michael
– sequence: 8
  givenname: Hans-Ulrich
  surname: Häring
  fullname: Häring, Hans-Ulrich
– sequence: 9
  givenname: Andreas
  surname: Fritsche
  fullname: Fritsche, Andreas
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16935751$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15855254$$D View this record in MEDLINE/PubMed
BookMark eNqF0c2KFDEQB_AgK-7s6s2z5KIne81np3MRhsH9gAFFVvDWZNLVTIbupE3Sq_MGnn1En8SMM7AXwUsKkh9VpP4X6MwHDwi9pOSKMkre7ewVI0RUTCj9BC2oFrJSVKsztCCE0Uor9vUcXaS0I4QKIfkzdE5lIyWTYoF-rN0DRHxtMja-w3c-zYPz-DMkl7LxFvAyQrnuYIJy-Dzs8TKlYJ3J0OHvLm9x3gL-_fOXpGL1_h5_CsN-DHHaujTi0P99vYXJZGfx2k0mAb4BD8_R094MCV6c6iX6cv3hfnVbrT_e3K2W68oKznJlFWFGNVQoLnj5lSW10b2QvTS1EQ0QprilRINRgnaEdWSjbU83na431HScX6I3x75TDN9mSLkdXbIwDMZDmFNbN4Q0NZf_hYzSRnGpC3x7hDaGlCL07RTdaOK-paQ9RNLubHuIpD1EUvirU995M0L3iE8ZFPD6BEyyZuhjWbtLj67WXCpJi-NHV4IINjoPU4SU2l2Yoy8r_Pf4P8hXpow
CODEN JCEMAZ
CitedBy_id crossref_primary_10_1038_oby_2007_568
crossref_primary_10_1097_01_hco_0000221579_25878_11
crossref_primary_10_1007_s00125_007_0788_8
crossref_primary_10_1016_j_jhep_2009_05_023
crossref_primary_10_1097_MOL_0b013e328338ca61
crossref_primary_10_1016_j_atherosclerosis_2013_12_013
crossref_primary_10_2217_clp_09_35
crossref_primary_10_1097_MCO_0b013e32830b5d09
crossref_primary_10_1016_j_jhep_2008_12_025
crossref_primary_10_2337_dc06_1161
crossref_primary_10_1007_s00109_006_0105_x
crossref_primary_10_1007_s00394_006_0619_6
crossref_primary_10_1016_j_numecd_2006_09_008
crossref_primary_10_1111_j_1741_4520_2011_00336_x
crossref_primary_10_1210_er_2008_0009
crossref_primary_10_1016_j_yexmp_2014_12_010
crossref_primary_10_1038_oby_2006_71
crossref_primary_10_3390_nu12072064
crossref_primary_10_1124_pr_108_00001
crossref_primary_10_1016_j_diabres_2020_108050
crossref_primary_10_1210_jc_2007_0482
crossref_primary_10_1016_j_metabol_2006_12_014
crossref_primary_10_1161_ATVBAHA_107_147538
crossref_primary_10_1530_EJE_08_0900
crossref_primary_10_1007_s00109_006_0138_1
ContentType Journal Article
Copyright 2005 INIST-CNRS
Copyright_xml – notice: 2005 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
8FD
FR3
P64
RC3
7X8
DOI 10.1210/jc.2004-2479
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 4243
ExternalDocumentID 10_1210_jc_2004_2479
15855254
16935751
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
02
08R
0R
1TH
29K
2WC
34G
39C
3O-
3V.
4.4
48X
53G
55
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABJS
AABMN
AAIMJ
AAJQQ
AAPQZ
AAQQT
AAUQX
AAWTL
AAYJJ
ABFLS
ABOCM
ABPMR
ABPPZ
ABSAR
ABUWG
ACGFS
ACIMA
ACPRK
ACUTJ
ADBBV
ADBIT
ADEIU
ADGZP
ADHKW
ADRTK
AELNO
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFNX
AFKRA
AFRAH
AFXEN
AGINJ
AGKRT
AGVJH
AHMBA
AIKOY
AIMBJ
ALMA_UNASSIGNED_HOLDINGS
APIBT
AQKUS
ARIXL
ASMCH
ASPBG
AVWKF
AYOIW
AZFZN
AZQFJ
BAWUL
BAYMD
BBAFP
BCRHZ
BENPR
BEYMZ
BGYMP
BHONS
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CDBKE
CS3
D-I
DAKXR
DIK
DPPUQ
E3Z
EBS
EIHJH
EJD
ENERS
F5P
FEDTE
FH7
FHSFR
FOTVD
FQBLK
FYUFA
G8K
GAUVT
GJ
GJXCC
GX1
H1
H13
HVGLF
HZ
H~9
IAO
IHR
INH
J5H
KBUDW
KOP
KQ8
KSN
L7B
M1P
M5
MBLQV
MHKGH
N9A
NLBLG
NOYVH
NVLIB
O0-
O9-
OBH
OCB
ODMLO
OGEVE
OK1
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
REU
ROX
ROZ
TCN
TJX
TLC
TMA
TWZ
VH1
WOQ
X
X52
X7M
XZ
ZA5
ZGI
ZXP
ZY1
---
-~X
.55
.GJ
.XZ
08P
0R~
18M
354
AABZA
AACZT
AAKAS
AAPGJ
AAPXW
AAUGY
AAVAP
AAWDT
ABBLC
ABLJU
ABPQP
ABPTD
ABWST
ABXZS
ACFRR
ACGFO
ACYHN
ADGKP
ADVEK
ADZCM
AERZD
AFFZL
AFGWE
AFOFC
AFXAL
AFYAG
AGQXC
AGUTN
AI.
AJEEA
ALXQX
APJGH
AQDSO
BYORX
CASEJ
EMOBN
FECEO
FLUFQ
FOEOM
HZ~
IQODW
KSI
M5~
MJL
N4W
NOMLY
OAUYM
OBFPC
OFXIZ
OHH
OPAEJ
OVIDX
P6G
TEORI
TR2
VVN
W8F
WHG
YBU
YFH
YHG
YOC
YSK
~02
~H1
AARHZ
AAUAY
ABJNI
ABMNT
ABNHQ
ABQNK
ABXVV
ACZBC
ADQBN
AGMDO
ATGXG
AVNTJ
CGR
CUY
CVF
ECM
EIF
ITC
NPM
OJZSN
AAYXX
CITATION
8FD
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c432t-c702a78147343197c06a9f45f5a6a48e0273c109ea741d02d0b9cf1bd96b1ad33
ISSN 0021-972X
IngestDate Fri Oct 25 02:01:18 EDT 2024
Fri Oct 25 00:56:34 EDT 2024
Thu Sep 26 15:17:12 EDT 2024
Sat Sep 28 07:44:08 EDT 2024
Sun Oct 22 16:05:47 EDT 2023
Tue Jan 05 21:44:36 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Visceral fat
Pancreatic hormone
Genetic variability
Digestive system
Enzyme
Liver
Triacylglycerol lipase
Genotype
Esterases
Insulin
Carboxylic ester hydrolases
Target tissue resistance
Hydrolases
Insulin resistance
Endocrinology
Polymorphism
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c432t-c702a78147343197c06a9f45f5a6a48e0273c109ea741d02d0b9cf1bd96b1ad33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/jcem/article-pdf/90/7/4238/10776374/jcem4238.pdf
PMID 15855254
PQID 21187359
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_68008635
proquest_miscellaneous_21187359
crossref_primary_10_1210_jc_2004_2479
pubmed_primary_15855254
pascalfrancis_primary_16935751
endocrinepress_journals_10_1210_jc_2004_2479
PublicationCentury 2000
PublicationDate 2005-07-01
PublicationDateYYYYMMDD 2005-07-01
PublicationDate_xml – month: 07
  year: 2005
  text: 2005-07-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2005
Publisher Endocrine Society
Publisher_xml – name: Endocrine Society
SSID ssj0014453
Score 2.013507
Snippet Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a...
Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific...
CONTEXT: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a...
CONTEXTLiver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a...
SourceID proquest
crossref
pubmed
pascalfrancis
endocrinepress
SourceType Aggregation Database
Index Database
Publisher
StartPage 4238
SubjectTerms Adult
Biological and medical sciences
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Cross-Sectional Studies
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Humans
Insulin Resistance
Lipase - genetics
Lipid Metabolism
Liver - metabolism
Male
Medical sciences
Polymorphism, Genetic
PPAR gamma - genetics
Vertebrates: endocrinology
Title Liver Fat and Insulin Resistance Are Independently Associated with the −514C>T Polymorphism of the Hepatic Lipase Gene
URI http://dx.doi.org/10.1210/jc.2004-2479
https://www.ncbi.nlm.nih.gov/pubmed/15855254
https://search.proquest.com/docview/21187359
https://search.proquest.com/docview/68008635
Volume 90
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAPQ9wpl-EH9jSCEjuX5gUJqo0JsT11Ut8ixxdt0DZVm04a_4f_yTm20yRolYCXqIpTJ8r3xT7H_s45hLyLFE-ilImAMwUOihrpQKSCBwroJFUWy4xhcPLZeXp6EX-dJtPB4FdHtbSpyw_y561xJf-DKpwDXDFK9h-Q3XYKJ-A34AtHQBiOf4XxNxRVHBlR-xxKTlYODjQahTYUYIU5QZpCt_Xs5kh4OBrVOdqdAZgz40N-PMGSDTfzCl49ls7w6oFLvbRZXWdXS5jxsORyTz2EPOukn9hGWsIdKxiRFm2Op7mugXGzJmehExMbtwB7Xq1Q4d1uC13aHfzY-LpgV7MfXZEu6kfsGu8Jpi2qui1N0Wf8_-cxhpb2FjaSrQi2DTSIgjyz1da3g7WrLepJmXVGXjALR7dOCeDT4pRg01XGAYtd7ZoOO5ZzS48IHKeEuYzWf6TgbprukLsMxjNUDn6ZbpVE4JL6ZKf-eX18BQZHdW9rK0C5jnpG0H4DiJM-ozpXrAEo4yqr7HZ9rAk0eUgeeN-FfnJEfEQGevGY3Dvz6own5NrykQIfKeBNPR9py0cKfKQ9PtKWjxT5SIFx1PLx44R22UgrY9s8G6ljI0U2PiUXJ8eT8Wng63oEMuasDmQWMoGp1jIO5mueyTAVuYkTk8AwEY80pliSUZhrAeauCpkKy1yaqFR5WkZCcf6M7C2qhX5BqEy1KkexMoxL8N1NLnMFNjvjShleKj0kh82LLpYufUuBbi9gU3yXWIM1LhCbIXnfR6HwX856x-UHPYzavtOc407mkLxtQCtgvMZNOLHQ1WZdMPDoM57ku69IR7jOwJMhee7Qbnv39Hm5s-UVud9-Sq_JXr3a6DdgNdflgeXsb1_CwzI
link.rule.ids 315,783,787,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liver+fat+and+insulin+resistance+are+independently+associated+with+the+-514C%3ET+polymorphism+of+the+hepatic+lipase+gene&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Stefan%2C+Norbert&rft.au=Sch%C3%A4fer%2C+Silke&rft.au=Machicao%2C+Fausto&rft.au=Machann%2C+J%C3%BCrgen&rft.date=2005-07-01&rft.issn=0021-972X&rft.volume=90&rft.issue=7&rft.spage=4238&rft_id=info:doi/10.1210%2Fjc.2004-2479&rft_id=info%3Apmid%2F15855254&rft.externalDocID=15855254
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon